Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease

被引:3
|
作者
Prevots, D. Rebecca [1 ]
Marras, Theodore K. [2 ,3 ]
Wang, Ping [4 ]
Mange, Kevin C. [4 ]
Flume, Patrick A. [5 ]
机构
[1] NIAID, Epidemiol & Populat Studies Unit, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Univ Hlth Network, Dept Resp Med, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Insmed Inc, Bridgewater, NJ USA
[5] Med Univ South Carolina, Div Pulm Crit Care Allergy & Sleep Med, Charleston, SC 29425 USA
基金
美国国家卫生研究院;
关键词
KEY WORDS; hospitalization; nontuberculous mycobacterial pulmonary disease; US Medicare; LUNG-DISEASE; PREVALENCE; MORTALITY;
D O I
10.1016/j.chest.2021.07.034
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Nontuberculous mycobacterial pulmonary disease (NTM-PD) is an uncommon mycobacterial infection characterized by worsening lung function and increased health care resource utilization; however, the overall risk for hospitalization among patients with RESEARCH QUESTION: What is the hospitalization risk among older adults with NTM-PD? STUDY DESIGN AND METHODS: A retrospective, nested, case-control study was conducted by using the Medicare claims database. Cases were defined as patients with $ 2 NTM-PD claims $ 30 days apart between January 1, 2007, and December 31, 2015. The study included individuals aged $ 65 years with $ 12 months of continuous enrollment in both Parts A and B before the first NTM-PD diagnosis. Cases were matched 1:2 to Medicare beneficiaries without NTM-PD (control subjects) according to age and sex. Hospitalizations following the first NTM-PD claim were compared between case and control subjects by using univariate and multivariate analyses. RESULTS: A total of 35,444 case subjects and 65,467 matched control subjects (mean age, 76.6 years; 70% female; $ 87% White) were identified. Baseline comorbidities, particularly pulmonary comorbidities, were more common in case subjects than in control subjects (81.1% vs 17.7% for COPD; 44.6% vs 0.6% for bronchiectasis). All-cause hospitalization was observed in 65.7% of case subjects and 44.9% of control subjects. Unadjusted annual hospitalization rates were significantly (P < .05) greater among case subjects than control subjects. Case subjects also had a significantly shorter time to hospitalization than control subjects. The increased burden due to hospitalization was reflected in multivariate analysis adjusting for baseline comorbidities. All-cause hospitalization in patients with NTM-PD relative to control subjects was 1.2 times more likely (relative risk, 1.23; 95% CI, 1.21-1.25; P < .0001) with a 46% greater hazard (hazard ratio, 1.46; 95% CI, 1.43-1.50; P < .0001). INTERPRETATION: Patients with NTM-PD were significantly more likely to be hospitalized, had greater annualized hospitalization rates, and had shorter time to hospitalization than age- and sex-matched control subjects without NTM-PD. These findings highlight the significantly increased burden of hospitalizations among patients with NTM-PD.
引用
收藏
页码:2042 / 2050
页数:9
相关论文
共 50 条
  • [1] Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare Beneficiaries
    Adjemian, Jennifer
    Olivier, Kenneth N.
    Seitz, Amy E.
    Holland, Steven M.
    Prevots, D. Rebecca
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (08) : 881 - 886
  • [2] Incremental Mortality Associated with Nontuberculous Mycobacterial Lung Disease Among US Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease
    Wang, P.
    Marras, T. K.
    Alemao, E.
    Hassan, M.
    Chatterjee, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease
    Ping Wang
    Theodore K. Marras
    Mariam Hassan
    Anjan Chatterjee
    BMC Infectious Diseases, 23
  • [4] Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease
    Wang, Ping
    Marras, Theodore K.
    Hassan, Mariam
    Chatterjee, Anjan
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [5] Prevalence Of Pulmonary Nontuberculous Mycobacterial Infections Among US Medicare Beneficiaries, 1997-2007
    Adjemian, J.
    Olivier, K. N.
    Seitz, A. E.
    Holland, S.
    Prevots, D. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [6] Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease
    Marras, Theodore K.
    Campitelli, Michael A.
    Kwong, Jeffrey C.
    Lu, Hong
    Brode, Sarah K.
    Marchand-Austin, Alex
    Gershon, Andrea S.
    Jamieson, Frances B.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 928 - 931
  • [7] Nontuberculous mycobacterial pulmonary disease
    Johnson, Margaret M.
    Waller, Ernest Andrew
    Leventhal, Jack P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (03) : 203 - 210
  • [8] Nontuberculous mycobacterial pulmonary disease
    Ringshausen, F. C.
    Rademacher, J.
    INTERNIST, 2016, 57 (02): : 142 - 151
  • [9] Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis The Nontuberculous Mycobacterial Series
    Kumar, Kartik
    Loebinger, Michael R.
    CHEST, 2022, 161 (03) : 637 - 646
  • [10] Risk Factors For Deaths Associated With Pulmonary Nontuberculous Mycobacterial Disease
    Fleshner, M.
    Adjemian, J.
    Olivier, K. N.
    Claypool, R. J.
    Holland, S.
    Prevots, D. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183